Brain scans may predict OCD therapy success in children
NCT ID NCT07570108
First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 3 times
Summary
This study is testing whether functional MRI brain scans can predict and track how well children and teens with obsessive-compulsive disorder (OCD) respond to a type of therapy called Exposure and Response Prevention (ERP). Thirty participants aged 10 to 17 will receive 14 weekly ERP sessions, followed by booster sessions. They will undergo brain scans and symptom assessments before, during, and after therapy to see if brain connection patterns relate to symptom changes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Exposure and Response Prevention (ERP) therapy
- What this could lead to
- If successful, this could help doctors predict which children with OCD will benefit most from ERP therapy, personalizing treatment and saving time.
- What could go wrong
- This is a small, early-stage study with only 30 participants and no comparison group. The brain scan findings may not reliably predict therapy outcomes in larger, more diverse groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Nov 2026
An estimate. Start dates often move.
- Expected to finish
-
Nov 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
10 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 10 to 17 years at the time of initial consent. Participants who reach age 18 while enrolled may remain in the study after completing the adult re-consent process; no new participants age 18 years or older will be recruited. * DSM-5 diagnosis of obsessive-compulsive disorder, established through a clinical interview by a clinician. * Parent or guardian able to provide informed consent and participant able to provide assent. * Participant has sufficient English fluency to complete cognitive tasks and assessments. Parent or guardian English fluency is not required; interpreter support is available. Exclusion Criteria: * History or current evidence of a significant neurological disorder, including but not limited to seizure disorder, stroke, or traumatic brain injury with loss of consciousness. * Any standard MRI contraindication identified during initial screening or on the MRI safety checklist, including but not limited to ferromagnetic implants, certain medical devices or metal fragments, severe claustrophobia, or pregnancy. * Pregnancy at screening or pregnancy identified during study participation. * Active suicidal ideation. * Any psychiatric condition that, in the investigator's judgment, would interfere with study participation or data interpretation, including but not limited to psychotic disorders, bipolar disorders, severe neurodevelopmental disorders, intellectual disability, severe eating disorders, or recent significant substance use disorders within the past 6 months. Stable psychiatric comorbidities, including anxiety disorders, depressive disorders, ADHD, or tic disorders, are permitted if OCD remains the primary diagnosis. * Any medical, psychiatric, or situational factor judged by the investigator as likely to compromise participant safety, adherence, or data integrity.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obsessive - compulsive disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NewYork-Presbyterian Hospital / Weill Cornell Medicine
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Brain scans and biosamples: mapping why OCD looks so different in every person
- Can a gentle electrical current quiet Obsessive-Compulsive symptoms?
- Can magnetic pulses ease OCD in teens who Haven't improved?
- Can a focused electric field quiet the Brain's obsessive signals?